Key facts
- ClinTrial Research’s last known valuation is $185.0M (Apr 2001).
- It has raised $5.0M across 1 recorded rounds; the latest was Early Stage VC ($5.0M) in Nov 2025.
- Notable investors include Tarsadia Investments.
- Status: Acquired/Merged (Operating Subsidiary).
Investors
1- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for ClinTrial Research
Funding rounds
1 roundsAbout ClinTrial Research
Provider of clinical trial research and site management services intended to serve clinical trial sponsors and healthcare research sites. The company provides patient identification and recruitment, study startup support, site operations management, trial execution, and coordination across multiple therapeutic areas, thereby enabling clients to conduct clinical trials efficiently and expand their participation in research studies.
- Sector
- Healthcare
- HQ
- Durham, NC, United States
- Founded
- 1989
- Employees
- 24
- Website
- clintrialresearch.com/
- Ownership
- Acquired/Merged (Operating Subsidiary)
ClinTrial Research doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in ClinTrial Research shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on ClinTrial Research in its N-PORT filings yet. We sweep new filings monthly.